- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00937339
Effects of Whole Body Vibration in People With Chronic Stroke
The Effects of Exercise and Whole Body Vibration Training on Bone Health, Physical Fitness, and Neuromotor Performance in Individuals With Chronic Stroke: A Randomized Controlled Trial.
The overall aim of the proposed study is to determine whether whole body vibration is beneficial in promoting bone health, physical fitness and neuromotor performance in patients with chronic stroke.
Subjects in the experimental group will undergo whole body vibration therapy (1 session per day, 3 sessions per week) for 8 weeks. The vibration frequency used in this study will be 30Hz. The total duration of exposure to vibration for the experimental group will be 10 minutes. While standing on the vibration platform, patients will be instructed to repeat the following set of light exercises: (1) light squatting,(2) deep squatting, (3) side-to-side weight-shift, (4) Forward and backward weight-shift, (5) forward lunge, (6) marching on the spot. The control exercise group, on the other hand, will perform the same exercise program on the platform, but no vibration will be given. The training will be conducted by a qualified personnel with physiotherapy background.
The outcome measurement will be performed 4 times: (1) immediately before the commencement of intervention, (2) immediately after termination of treatment, (3) at 1 month after termination of treatment. Each subject will be evaluated for bone markers, leg muscle strength, balance, spasticity, and walking ability.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hong Kong, China
- Hong Kong Polytechnic University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- a diagnosis of stroke more than 6 months
- medically stable
- able to understand verbal commands
- Abbreviated mental test score 6 or above
- age >18
- able to stand with or without aids for at least 1.5 minutes
Exclusion Criteria:
- neurological conditions other than stroke
- significant musculoskeletal conditions (e.g. amputations)
- metal implants in the lower extremity
- previous fracture of the lower extremity
- are currently taking bone resorption inhibitors or were taking the same before stroke.
- significant peripheral vascular disease
- vestibular disorders
- pregnancy
- Other serious illnesses that preclude the person from participating in the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control
The control group will perform the same exercises on the vibration platform, as in the experimental group.
However, the vibration device will be turned off during the exercises.
|
Control group: One session per day, 3 sessions per week, for consecutive 8 weeks.
The subjects will perform the same exercises on the vibration platform but no vibration will be applied.
Other Names:
|
|
Experimental: Whole body vibration
Subjects in the experimental group will undergo whole body vibration (1 session per day, 3 sessions per week) for 8 weeks.
The vibration loading will be carried out using the Jet-Vibe System (Danil SMC Co., Ltd., Seoul, Korea).
The vibration protocol used in this study will be 30Hz.
While standing on the vibration platform, patients will be instructed to repeat the following set of light exercises: (1) light squatting,(2)deep squatting , (3) side-to-side weight-shift, (4) Forward and backward weight-shift, (5) forward lunge, (6) marching on the spot.
The total duration of exposure of whole body vibration per session will be about 10 minutes.
|
Experimental group: One session per day, 3 sessions per week, for consecutive 8 weeks.
The total duration of whole body vibration therapy will be about 10 minutes per session.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Paretic knee concentric muscle strength
Time Frame: pre-test (week 0)
|
pre-test (week 0)
|
|
Paretic knee concentric muscle strength
Time Frame: Post-test (week 8)
|
Post-test (week 8)
|
|
Paretic knee concentric muscle strength
Time Frame: Follow-up (week 12)
|
Follow-up (week 12)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Non-paretic concentric knee muscle strength
Time Frame: Pre-test (week 0)
|
Pre-test (week 0)
|
|
Non-paretic knee concentric muscle strength
Time Frame: Post-test (week 8)
|
Post-test (week 8)
|
|
Non-paretic knee concentric muscle strength
Time Frame: Follow-up (week 12)
|
Follow-up (week 12)
|
|
Paretic knee eccentric muscle strength
Time Frame: pre-test (week 0)
|
pre-test (week 0)
|
|
Paretic knee eccentric muscle strength
Time Frame: Post-test (week 8)
|
Post-test (week 8)
|
|
Paretic knee eccentric muscle strength
Time Frame: WFollow-up (week 12)
|
WFollow-up (week 12)
|
|
Non-paretic knee eccentric muscle strength
Time Frame: Pre-test (week 0)
|
Pre-test (week 0)
|
|
Non-paretic knee eccentric muscle strength
Time Frame: Post-test (week 8)
|
Post-test (week 8)
|
|
Non-paretic knee eccentric muscle strength
Time Frame: Follow-up (week 12)
|
Follow-up (week 12)
|
|
Paretic knee isometric muscle strength
Time Frame: Pre-test (week 0)
|
Pre-test (week 0)
|
|
Paretic knee isometric muscle strength
Time Frame: Post-test (week 8)
|
Post-test (week 8)
|
|
Paretic knee isometric muscle strength
Time Frame: Follow-up (week 12)
|
Follow-up (week 12)
|
|
Non-paretic knee isometric muscle strength
Time Frame: Pre-test (week 0)
|
Pre-test (week 0)
|
|
Non-paretic knee isometric muscle strength
Time Frame: Post-test (week 8)
|
Post-test (week 8)
|
|
Non-paretic knee isometric muscle strength
Time Frame: Follow-up (week 12)
|
Follow-up (week 12)
|
|
Limit of stability test
Time Frame: Pre-test (week 0)
|
Pre-test (week 0)
|
|
Limit of stability test
Time Frame: Post-test (week 8)
|
Post-test (week 8)
|
|
Limit of stability test
Time Frame: Follow-up (week 12)
|
Follow-up (week 12)
|
|
Berg balance test
Time Frame: Pre-test (week 0)
|
Pre-test (week 0)
|
|
Berg balance test
Time Frame: Post-test (week 12)
|
Post-test (week 12)
|
|
Berg balance test
Time Frame: Follow-up (week 12)
|
Follow-up (week 12)
|
|
Activities-specific Balance Confidence Scale
Time Frame: Pre-test (week 0)
|
Pre-test (week 0)
|
|
Activities-specific Balance Confidence Scale
Time Frame: Post-test (week 8)
|
Post-test (week 8)
|
|
Activities-specific Balance Confidence Scale
Time Frame: Follow-up (week 12)
|
Follow-up (week 12)
|
|
Six Minute Walk Test
Time Frame: Pre-test (week 0)
|
Pre-test (week 0)
|
|
Six Minute Walk Test
Time Frame: Post-test (week 8)
|
Post-test (week 8)
|
|
Six Minute Walk Test
Time Frame: Follow-up (week 12)
|
Follow-up (week 12)
|
|
Self-selected gait velocity
Time Frame: Pre-test (week 0)
|
Pre-test (week 0)
|
|
Self-selected gait velocity
Time Frame: post-test (week 8)
|
post-test (week 8)
|
|
Self-selected gait velocity
Time Frame: Follow-up (week 12)
|
Follow-up (week 12)
|
|
Bone formation marker level
Time Frame: pre-test (week 0)
|
pre-test (week 0)
|
|
Bone formation marker level
Time Frame: Post-test (week 8)
|
Post-test (week 8)
|
|
Bone resorption marker level
Time Frame: pre-test (week 0)
|
pre-test (week 0)
|
|
Bone formation marker level
Time Frame: Follow-up (week 12)
|
Follow-up (week 12)
|
|
Bone resorption marker level
Time Frame: post-test (week 8)
|
post-test (week 8)
|
|
Bone resorption marker level
Time Frame: Follow-up (week 12)
|
Follow-up (week 12)
|
|
fall rate
Time Frame: 6 months after termination of treatment
|
6 months after termination of treatment
|
|
Knee spasticity
Time Frame: Pre-test (week 0)
|
Pre-test (week 0)
|
|
Knee spasticity
Time Frame: Post-test (week 8)
|
Post-test (week 8)
|
|
Knee spasticity
Time Frame: Follow-up (week 12)
|
Follow-up (week 12)
|
|
Ankle spasticity
Time Frame: Pre-test (week 0)
|
Pre-test (week 0)
|
|
Ankle spasticity
Time Frame: Post-test (week 8)
|
Post-test (week 8)
|
|
Ankle spasticity
Time Frame: Follow-up (week 12)
|
Follow-up (week 12)
|
|
Level of satisfaction
Time Frame: Post-test (week 8)
|
Post-test (week 8)
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSEARS20090520002-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
University Hospital HeidelbergCompletedAcute Ischemic Stroke | Acute Ischemic Stroke AIS | Acute Ischemic Stroke PatientsGermany
Clinical Trials on Exercise on the vibration platform with the device turned off
-
Trakya UniversityCompleted
-
Universidade do Vale do ParaíbaCompleted
-
The Hong Kong Polytechnic UniversityTung Wah HospitalUnknown
-
Klinikum der Universität KölnUnknownChanges in Six Minute Walking Distance, Peak Oxygen Uptake, Quality of LifeGermany
-
University of Castilla-La ManchaCompleted
-
Hopital FochCompleted
-
National Cheng Kung UniversityCompleted
-
University of Erlangen-Nürnberg Medical SchoolUniversitätsklinikum Hamburg-Eppendorf; University Hospital FrankfurtCompleted
-
Centre Hospitalier Universitaire DijonCompleted
-
Inonu UniversityNot yet recruitingBreast Cancer | Pain Management | Fear | Injection Fear | Injection Pain PreventionTurkey (Türkiye)